Gene · 2355
Papers2,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting AKR1B1 inhibits metabolic reprogramming to reverse systemic therapy resistance in hepatocellular carcinoma. | Signal Transduct Target Ther | 2025 | 40750772 | PubTator, text mining | PubMed |
| "Molecular pigeon" network of lncRNA and miRNA: decoding metabolic reprogramming in patients with lung cancer. | Front Oncol | 2025 | 40746614 | PubTator, text mining | PubMed |
| Positional distribution of transcription factor binding sites in the human genome. | PLoS One | 2025 | 40737245 | PubTator, text mining | PubMed |
| Deciphering transcriptomic signatures in schizophrenia, bipolar disorder, and major depressive disorder. | Front Psychiatry | 2025 | 40727846 | PubTator, text mining | PubMed |
| Modeling combinatorial regulation from single-cell multi-omics provides regulatory units underpinning cell type landscape using cRegulon. | Genome Biol | 2025 | 40707940 | PubTator, text mining | PubMed |
| Comprehensive analysis of keloid super-enhancer networks reveals FOXP1-mediated anti-senescence mechanisms in fibrosis. | Cell Mol Biol Lett | 2025 | 40702440 | PubTator, text mining | PubMed |
| Microarray Analysis Reveals Sepsis Is a Syndrome with Hyperactivity of TH17 Immunity, with Over-Presentation of the Treg Cell Cytokine TGF-β. | Curr Issues Mol Biol | 2025 | 40699834 | PubTator, text mining | PubMed |
| A comprehensive analysis of transcription factors identified TCF3 as a prognostic target for glioma. | Sci Rep | 2025 | 40653505 | PubTator, text mining | PubMed |
| Retraction notice to "MiR-124-3p suppresses glioma aggressiveness via targeting of Fra-2" [Pathol. - Res. Pract. 214 (2018) 1825-1834]. | Pathol Res Pract | 2025 | 40628556 | PubTator, text mining | PubMed |
| Resident memory T cell development is gradual and shows AP-1 gene expression in mature cells. | JCI Insight | 2025 | 40548376 | PubTator, text mining | PubMed |
| Circ-myh8/KAT7 Affects PANoptosis in Pulmonary Arterial Smooth Muscle Cells: Involvement of Super-Enhancers in FOSL2 Expression. | J Am Heart Assoc | 2025 | 40530493 | PubTator, text mining | PubMed |
| Transcriptional regulatory logic orchestrating lymphoid and myeloid cell fate decisions. | Front Immunol | 2025 | 40510370 | PubTator, text mining | PubMed |
| STAT3 Facilitates Super Enhancer Formation to Promote Fibroblast-To-Myofibroblast Differentiation by the Analysis of ATAC-Seq, RNA-Seq and ChIP-Seq. | J Cell Mol Med | 2025 | 40464702 | PubTator, text mining | PubMed |
| Biodentine Stimulates Calcium-Dependent Osteogenic Differentiation of Mesenchymal Stromal Cells from Periapical Lesions. | Int J Mol Sci | 2025 | 40362457 | PubTator, text mining | PubMed |
Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1. | Ann Rheum Dis | 2025 | 40348637 | PubTator, text mining | PubMed |
| Effect of MiRNA 204-5P Mimics and Lipopolysaccharide-Induced Inflammation on Transcription Factor Levels, Cell Maintenance, and Retinoic Acid Signaling in Primary Limbal Epithelial Cells. | Int J Mol Sci | 2025 | 40332443 | PubTator, text mining | PubMed |
| Mechanism of miR-200b-3p-induced FOSL2 inhibition of endometrial cancer cell proliferation and metastasis. | Sci Rep | 2025 | 40325054 | PubTator, text mining | PubMed |
| Editorial: Sex differences in sleep and circadian rhythms. | Front Neurosci | 2025 | 40201192 | PubTator, text mining | PubMed |
| KLF6-mediated recruitment of the p300 complex enhances H3K23su and cooperatively upregulates SEMA3C with FOSL2 to drive 5-FU resistance in colon cancer cells. | Exp Mol Med | 2025 | 40082673 | PubTator, text mining | PubMed |
| A pathogenic subpopulation of human glioma associated macrophages linked to glioma progression. | bioRxiv | 2025 | 40027797 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2355/papers?page=6